Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Weiming Kaituo Agriculture Biotechnology is a leading Chinese agricultural biotechnology company focused on crop genetic improvement. Established in 2000 as a joint venture involving Peking University and the Chinese Academy of Sciences, the company specializes in gene discovery, molecular breeding, and the development of transgenic traits for major crops like rice, maize, and wheat. It operates a comprehensive platform for functional genomics and high-throughput genetic transformation, providing essential services to the seed industry. The company's research aims to enhance crop yield, stress tolerance, and nutritional value to support food security. Weiming Kaituo is recognized as a key innovator in China's domestic agricultural biotech sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Weiming Kaituo Agriculture Biotechnology.